eccogene glp-1 obtains exclusive license from AstraZeneca to develop and sell ECC5004, a receptor agonist for cardio-metabolic diseases XBRL Viewer
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17



























